Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 09, 2021 Filed Nov 12, 2021 21:15 UTC |
Nielsen JackDirector
|
ConversionCommon Stock | 2,365,545 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-21-037652 · form4.xml · nonDerivative · entry 1 Nielsen Jack · CIK 0001602402 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,365,545 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Upon the closing of the Issuer's initial public offering, each share of Series C Preferred Stock beneficially owned by the reporting person automatically converted, for no additional consideration, into the number of shares of Common Stock reported in Column 7 of Table II. These shares of Series C Preferred Stock had no expiration date. F2 · ownership.nature: The securities are held by Vivo Capital Fund IX, L.P. ("Fund IX"). Vivo Capital IX, LLC ("Capital IX") is the general partner of Fund IX. The reporting person is a managing member of Capital IX and may be deemed to share voting and investment power with respect to the shares beneficially owned by Fund IX and disclaims Section 16 beneficial ownership of such securities held by Fund IX, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| November 04, 2021 Filed Nov 8, 2021 18:33 UTC |
Zocca Mai-BrittDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 414,212 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001140361-21-037038 · form4.xml · derivative · entry 1 Zocca Mai-Britt · CIK 0001890736 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 414,212 Underlying: Common Stock · 414,212 shares Expires 2031-11-04 F1 · derivative.exercise_date: These options vest in 1/48 monthly increments of the vesting commencement date of November 4, 2021, subject to the reporting person's continued service through the applicable vesting date, and subject to 50% acceleration upon a change of control and subject to 100% acceleration upon termination of service by the Issuer without cause or by the reporting person within 24 months of a change of control. Read SEC document |
| November 04, 2021 Filed Nov 8, 2021 23:39 UTC |
Glaub Kathleen SeredaDirector
|
GrantStock Option (Right to Buy) · Derivative | 21,295 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001140361-21-037044 · form4.xml · derivative · entry 1 Glaub Kathleen Sereda · CIK 0001619612 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,295 Underlying: Common Stock · 21,295 shares Expires 2031-11-04 F1 · derivative.exercise_date: These options vest annually over three years from the vesting commencement date of November 4, 2021, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control. Read SEC document |
| November 04, 2021 Filed Nov 8, 2021 23:37 UTC |
Vendola Keith A.Chief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 69,469 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001140361-21-037042 · form4.xml · derivative · entry 1 Vendola Keith A. · CIK 0001740994 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,469 Underlying: Common Stock · 69,469 shares Expires 2031-11-04 F1 · derivative.exercise_date: These options vest 25% on the one-year anniversary of the vesting commencement date of November 4, 2021, and then in 1/48 monthly increments thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 50% acceleration upon a change of control and subject to 100% acceleration upon termination of service by the Issuer without cause or by the reporting person within 24 months of a change of control. Read SEC document |
| November 04, 2021 Filed Nov 8, 2021 23:35 UTC |
Hirth PeterDirector
|
GrantStock Option (Right to Buy) · Derivative | 34,731 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001140361-21-037040 · form4.xml · derivative · entry 1 Hirth Peter · CIK 0001813780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,731 Underlying: Common Stock · 34,731 shares Expires 2031-11-04 F1 · derivative.exercise_date: These options vest annually over three years from the vesting commencement date of November 4, 2021, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.